Discontinued — last reported Q1 '26
Adempas — Intangible assets
Merck & Co. Adempas — Intangible assets decreased by 14.6% to $239.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 32.3%, from $353.00M to $239.00M. Over 4 years (FY 2021 to FY 2025), Adempas — Intangible assets shows a downward trend with a -22.3% CAGR.
Analysis
How to read this metric
A decrease typically indicates ongoing amortization or potential impairment, while an increase suggests new capital investment or acquisitions related to the product's intellectual property portfolio.
Detailed definition
This metric represents the net book value of capitalized intangible assets specifically associated with the Adempas prod...
Peer comparison
Comparable to capitalized product rights or acquired intangible assets reported by other pharmaceutical companies for specific drug franchises.
mrk_segment_adempas_intangible_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $920.00M | $869.00M | $806.00M | $758.00M | $691.00M | $597.00M | $633.00M | $613.00M | $586.00M | $533.00M | $526.00M | $483.00M | $445.00M | $431.00M | $372.00M | $353.00M | $348.00M | $312.00M | $280.00M | $239.00M |
| QoQ Change | — | -5.5% | -7.2% | -6.0% | -8.8% | -13.6% | +6.0% | -3.2% | -4.4% | -9.0% | -1.3% | -8.2% | -7.9% | -3.1% | -13.7% | -5.1% | -1.4% | -10.3% | -10.3% | -14.6% |
| YoY Change | — | — | — | — | -24.9% | -31.3% | -21.5% | -19.1% | -15.2% | -10.7% | -16.9% | -21.2% | -24.1% | -19.1% | -29.3% | -26.9% | -21.8% | -27.6% | -24.7% | -32.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s adempas — intangible assets?
- Merck & Co. (MRK) reported adempas — intangible assets of $239.00M in Q1 2026.
- How has Merck & Co.'s adempas — intangible assets changed year-over-year?
- Merck & Co.'s adempas — intangible assets decreased by 32.3% year-over-year, from $353.00M to $239.00M.
- What is the long-term trend for Merck & Co.'s adempas — intangible assets?
- Over 4 years (2021 to 2025), Merck & Co.'s adempas — intangible assets has grown at a -22.3% compound annual growth rate (CAGR), from $3.54B to $1.29B.
- What does adempas — intangible assets mean?
- The remaining accounting value of patents and intellectual property rights tied to the Adempas product line.